Clovis Oncology Inc (CLVS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5500 FLATIRON PARKWAY BOULDER, CO 80301

Clovis Oncology, Inc. develops and commercializes anti-cancer pharmaceutical drugs. The company develops CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine, which is in Phase III clinical trials for first-line treatment of metastatic pancreatic cancer; Phase II clinical trials for second-line treatment of metastatic pancreatic cancer; and preclinical trials for solid tumors. Its products also include CO-1686, a small molecule epidermal growth factor receptor, which is in preclinical trials for the treatment of non-small cell lung cancer; and CO-338, a small molecule PARP inhibitor, which is in Phase II clinical trials for the adjuvant treatment of hereditary, or germ-line, BRCA mutant, and triple-negative breast cancer, as well as Phase I clinical trials for the treatment of solid tumors. The company intends to sell its products through distributors in the United States, Europe, and internationally. Clovis Oncology, Inc. was founded in 2009 and is based in Boulder, Colorado.

Data based on most recent fiscal year report
Market Cap2.461 Billion Shares Outstanding49.02 Million Avg Volume2.62 Million
1-Yr BETA vs S&P TR Current Ratio7.69 Quick Ratio7.35
View SEC Filings from CLVS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade CLVS now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 163 35 (3.62%)
Aggregate 13F shares on 06/30/2019: 50.094 Million 20.305 Million
Aggregate 13F shares on 03/31/2019: 49.395 Million 23.569 Million
Percent change: 1.41% -13.85%
Funds creating new positions: 24 8
Funds Adding to an existing position: 70 17
Funds closing out their position: 41 8
Funds reducing their position: 39 8
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

20 Thousand total shares from 1 transactions

Open Market Sells (S)

5.2 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

36.4 Thousand total shares from 12 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GRAHAM GINGER L

  • Director
53,304 2019-10-01 1

MOTT DAVID M

  • Director
4,443,435 2019-09-30 0

IVERS-READ GILLIAN C SEE REMARKS

  • Officer
193,509 2019-09-20 9

ROLFE LINDSEY SEE REMARKS

  • Officer
23,881 2019-09-20 9

SANDELL SCOTT D

  • Director
  • 10% Owner
4,059,376 2019-09-17 0

FAIR RICHARD A. PRESIDENT AND CEO

  • Officer
  • Director
66,561 2019-09-10 1

MUEHL DANIEL W SEE REMARKS

  • Officer
9,065 2019-09-04 10

GROSS PAUL EDWARD SEE REMARKS

  • Officer
5,935 2019-09-04 5

MAHAFFY PATRICK J

  • Director
30,824 2019-08-29 2

ATWOOD BRIAN G

  • Director
153,294 2019-08-20 2

SPICKSCHEN THORLEF

  • Director
58,176 2019-08-16 4

BLAIR JAMES C

  • Director
63,544 2019-08-16 4

KAMDAR KIM P.

  • Director
27,148 2019-08-06 0

KLINGENSTEIN PAUL H

  • Director
711,160 2019-07-29 2

BARRIS PETER J

  • 10% Owner
4,186,243 2019-07-22 0

BASKETT FOREST

  • 10% Owner
4,186,243 2019-07-22 0

HALAK BRIAN K

  • Director
0 2019-06-19 0

ALLEN ANDREW R

  • Director
0 2019-06-11 0

MCKINLEY EDWARD J

  • Director
0 2019-06-06 1

HOERTER STEVEN L.

  • Director
0 2019-06-06 0

FLAHERTY KEITH T.

  • Director
0 2019-06-06 1

AZELBY ROBERT

  • Director
0 2019-06-06 1

TREU JESSE I

  • Director
0 2019-06-04 0

BARRETT M JAMES

  • Director
0 2019-05-30 0

VITULLO NICOLE

  • Director
13,286 2019-05-29 0

MAST ERLE T

  • Director
0 2019-05-22 0

KRAMLICH C RICHARD

  • Director
0 2019-05-20 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
0 2019-01-22 0

KERINS PATRICK J

  • 10% Owner
0 2019-01-22 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
5,174,727 2019-01-14 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

FAIR RICHARD A.

FAIR RICHARD A.

  • Director
0 2018-10-11 1

HOOKS CORWIN DALE SEE REMARKS

  • Officer
5,349 2018-09-05 0

DOVEY BRIAN H

  • Director
3,722,188 2018-06-29 0

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
No longer subject to file 2017-11-06 0

NEW ENTERPRISE ASSOCIATES 13 LP

  • 10% Owner
No longer subject to file 2017-11-06 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

WELLER HARRY R

  • 10% Owner
3,490,073 2016-10-31 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

SCHOEMAKER KATHLEEN K

HALAK BRIAN K

  • 10% Owner
17,947 2015-08-18 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

SCHOEMAKER KATHLEEN K

HALAK BRIAN K

  • 10% Owner
1,052,328 2015-08-18 0

DRANT RYAN D

  • 10% Owner
7,489,485 2015-06-05 0

DOMAIN PARTERS VII L P

  • 10% Owner
No longer subject to file 2014-03-19 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
No longer subject to file 2014-03-19 0

DP VII ASSOCIATES LP

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN ASSOCIATES

  • 10% Owner
No longer subject to file 2014-03-19 0

REED JOHN C

  • Director
0 2012-09-04 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-20 M 1,875 d 9,375 193,509.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-20 S 1,744 $4.80 d 23,881 23,881.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-20 S 837 $4.80 d 193,509 193,509.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-20 M 3,437 a 25,625 23,881.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-20 M 1,875 a 194,346 193,509.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-20 M 3,437 d 17,188 23,881.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-04 M 688 d 6,875 22,188.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-04 M 688 a 22,563 22,188.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-09-04 M 563 d 5,625 9,065.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-09-04 M 563 a 9,335 9,065.00 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2019-09-04 M 563 d 5,625 5,935.00 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2019-09-04 M 563 a 6,205 5,935.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-04 M 688 d 6,875 192,471.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-04 M 688 a 192,801 192,471.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-04 M 625 d 3,750 22,188.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-04 S 341 $5.21 d 21,875 22,188.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-09-04 M 469 d 2,813 9,065.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-09-04 S 225 $5.21 d 8,772 9,065.00 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2019-09-04 M 469 d 2,813 5,935.00 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2019-09-04 S 225 $5.21 d 5,642 5,935.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-04 M 625 d 3,750 192,471.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-04 S 300 $5.21 d 192,113 192,471.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-04 S 375 $5.21 d 22,188 22,188.00 direct

ROLFE LINDSEY - Officer SEE REMARKS

2019-09-04 M 625 a 22,216 22,188.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-09-04 S 270 $5.21 d 9,065 9,065.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-09-04 M 469 a 8,997 9,065.00 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2019-09-04 S 270 $5.21 d 5,935 5,935.00 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2019-09-04 M 469 a 5,867 5,935.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-04 S 330 $5.21 d 192,471 192,471.00 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2019-09-04 M 625 a 192,413 192,471.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-08-27 M 547 d 2,187 8,528.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-08-27 S 239 $6.09 d 8,528 8,528.00 direct

MUEHL DANIEL W - Officer SEE REMARKS

2019-08-27 M 547 a 8,767 8,528.00 direct

BLAIR JAMES C - Director by wife

2019-08-20 P 20,000 $5.97 a 20,000 63,544.00 indirect

ATWOOD BRIAN G - Director

2019-08-20 M 25,862 d 0 153,294.00 direct

ATWOOD BRIAN G - Director

2019-08-20 M 25,862 $0.29 a 25,862 153,294.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments